ViiV’s two-drug HIV regimen hits PhIII targets
admin 14th June 2018 Uncategorised 0ViiV Healthcare’s two-drug HIV regimen of Tivicay and Epivir has hit targets in late-stage trials, showing non-inferiority to a three-drug regimen and thus the potential to offer patients an alternative treatment strategy.
More: ViiV’s two-drug HIV regimen hits PhIII targets
Source: News